Advisory Board Co. (The)

Advisory Board Co. (The)

ABCO
Advisory Board Co. (The)US flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
The Advisory Board Company (ABCO) provides research, consulting, and technology solutions to healthcare organizations, universities, and other non-profit institutions. The company offers a range of products and services including benchmarking data, best-practice research reports, performance improvement tools, procurement advisory services, and software platforms for strategic planning and operational analytics; its key offerings encompass the Advisory Board Insights platform for data-driven decision-making, the Fellowship Program for executive development, and specialized consulting in areas such as revenue cycle management, physician alignment, and supply chain optimization. Founded in 1979 and headquartered in Washington, D.C., Advisory Board operates primarily in the United States with global reach through its research and technology services targeting hospitals, health systems, academic medical centers, and higher education institutions. In 2017, Advisory Board was acquired by UnitedHealth Group's Optum business unit in a $1.3 billion deal, integrating its capabilities into Optum's broader advisory and analytics portfolio to enhance value-based care strategies; this transaction marked a significant strategic shift, enabling expanded data integration and consulting scale for clients navigating healthcare transformation. More recently, in line with Optum's growth initiatives, Advisory Board has launched enhanced AI-powered analytics tools within its Insights platform and formed partnerships with major health systems for population health management solutions as of 2024-2025. The company continues to evolve under Optum, focusing on digital transformation and evidence-based advisory services amid ongoing industry consolidation.